一个案例报告 Orofacial Dyskinesia 与通过皮肤的甲基化物
Carson Rogge1, Elizabeth Barnhardt2
1The Ohio State University College of Medicine, Columbus, OH.
概括
一个患有自闭症谱系障碍的孩子在开始治疗ADHD的甲基化物后经历了暂时的动力障碍. 这凸显了需要识别ADHD和并发症儿童不良影响的危险因素的必要性.
科学领域:
- 儿科神经学 儿科神经学
- 神经发育障碍 神经发育障碍
背景情况:
- 甲基化物透皮系统是常见的ADHD治疗方法.
- 患有多动症的儿童通常有并发症.
研究的目的:
- 报告患有ADHD和自闭症谱系障碍的儿童患有动力障碍的病例,该病例是用甲基酸治疗的.
- 强调识别甲基酸诱导的伴随疾病儿童动障碍的危险因素的重要性.
主要方法:
- 一个9岁男孩的病例报告,患有多动症,自闭症谱系障碍和其他发育问题.
- 在启动甲基酸甲透皮系统后观察非自愿运动 (动力障碍).
- 停止使用甲基化物和症状的消失.
主要成果:
- 患者在开始服用甲基化物后出现过渡性动力障碍,包括唇和部运动.
- 在停止服用药物后,症状完全消失.
结论:
- 在患有多动症和并发症的儿童中,甲基胺治疗时,可能会出现失动症等不良反应.
- 个性化治疗计划需要了解患者特定的药物不耐受性风险因素.
更多相关视频
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.1K
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
14.6K
相关概念视频
Parkinson's Disease: Treatment
162
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
162
Direct-Acting Cholinergic Agonists: Therapeutic Uses
646
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
646
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Attention-Deficit/Hyperactivity Disorder
33
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
33
Cholinergic Antagonists: Pharmacokinetics
384
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
384
